With more than 60-70 million people are affected by gastrointestinal diseases every year, there remains a huge unmet medical need for more effective and better tolerated therapies in gastroenterology.
CD BioSciences offers extensive preclinical and clinical expertise in gastrointestinal diseases. In order to help our clients achieve the best chance of success in delivering new medical breakthroughs to the patients, we have grouped a dedicated strong gastroenterology team who understand the broad spectrum of digestive disorders.
Gastroenterology Theraprutic Area
There are hundreds of food allergies and food intolerances, and many symptoms manifest as digestive disorders and discomfort. Because this is a growing health concern worldwide, we are committed to supporting biopharmaceutical research for gastrointestinal diseases. Our clinical pharmacology capabilities cover a variety of gastroenterological indications, supported by a team of gastroenterologists, and other medical experts familiar with the supervision and treatment of gastrointestinal disorders.
Main gastrointestinal indications for the past five years:
Why Choose CD BioSciences?
We put all our attention into clinical development because we care about patients who are waiting for these more effective therapies. We invest in our therapeutic expertise by hiring some of the brightest people and implementing the latest innovations to give your novel therapies a better chance of success. By participating in our clinical development, you can benefit from simplified access to our extensive drug development experience.
Our clinical developement expertise includes:
Explore Our Clinical Services for a Complete Picture by Stage:
CD BioSciences' scientists are dedicated to bringing together years of valuable experience to help our clients shorten the clinical trial journey. For further details, please don't hesitate to contact us.
